module 5 treatment mepolizumab reslizumab benralizumab
Published 5 years ago • 1.3K plays • Length 15:25Download video MP4
Download video MP3
Similar videos
-
5:41
il-5–inhibiting agents mepolizumab, benralizumab, and reslizumab
-
5:38
module 4 treatment omalizumab
-
6:08
module 6 treatment duplimumab
-
9:57
module 3 treatment overview
-
1:02:16
anaemia in pregnancy diagnosis and management - obstetrics | prof. dhammike silva
-
5:45
nucala (mepolizumab) results for eczema, asthma, & allergy treatment. paradoxical reaction | ep.118
-
21:16
xolair
-
6:16
module 5 - expert analysis of emerging atopic dermatitis therapy studies
-
1:50
newly approved asthma treatment could be a game changer – 5 news
-
4:32
module 5: biosimilars—advances in research and development
-
5:09
reslizumab in adult, severe eosinophilic asthma
-
1:57
cinqair (reslizumab) - severe asthma
-
7:04
module 2 definition features
-
11:56
asthma education video modules: module 5—asthma warning signs and what to do
-
0:39
introduction
-
3:55
anti il5 and indicators for use
-
2:01
biologic treatments for asthma: what you need to know
-
1:26
the imsavar project: making immunomodulatory therapies safer
-
4:46
module 1 unmet needs pathobiology
-
2:59
journal club- pros of switching from omalizumab or mepolizumab to benralizumab in asthma patients